A carregar...
Real-World Observational Review of Andexanet Alfa Prescribing and Utilization Outcomes at a Community Teaching Hospital
OBJECTIVES: Andexanet alfa is the first approved antidote in the management of life-threatening bleeds in patients treated with Xa inhibitors. The ANNEXA-4 study was successful in reducing factor Xa levels during time of administration but lacked correlation to improved patient outcomes. Given its n...
Na minha lista:
| Publicado no: | Crit Care Explor |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8021330/ https://ncbi.nlm.nih.gov/pubmed/33834167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000356 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|